Study of Cognitive and Behavioral Impacts of Idiopathic Epilepsy and Antiepileptic Drugs (AEDs) in Children and Adolescents
Journal of Advances in Medicine and Medical Research,
Page 176-187
DOI:
10.9734/jammr/2022/v34i1931451
Abstract
Background: Epilepsy is a common neurological condition that can have a detrimental impact on social, emotional, and cognitive functioning. Psychiatric and cognitive problems in children with epilepsy and antiepileptic drugs can affect quality of life. Long-term follow-up studies reveal that epilepsy that develops in childhood is more common than epilepsy that develops later in life. Has a marked impact on adult life even when the epilepsy is not complicated by intellectual disability or other neurological impairments. The aim of this study was to study cognitive and behavioral impacts of idiopathic epilepsy and antiepileptic drugs in children and adolescents compared to normal ones.
Methods: This prospective, case control study was conducted on 60 children or adolescents suffering from idiopathic epilepsy aged 6-16 years. Children were classified into four equal groups and were examined after 6 months from diagnosis: Group A subjected to valproic acid at a dose of 10-60 mg/kg/day, group B subjected to Carbamazepine at a dose of 10-30 mg/kg/day, group C subjected to levetiracetam at a dose of 10-60 mg/kg/day and group D subjected to Oxcarbazepine at a dose of 20-30 mg/kg/day. Thirty healthy children or adolescents of matched age and sex served as a control group who attended Pediatric General Outpatient Clinic of Tanta University Hospitals. The following was done to all of the patients: full history taking, complete physical examination, routine laboratory investigations, electroencephalography, brain magnetic resonance imaging, specific tests for behavior and executive functions including the Child Behavior Checklist – school age, Stanford-Binet Intelligence Scales (fifth version), Wisconsin Card Sorting Test and Continuous Performance Test. Thirty healthy children or adolescents of matched age and sex served as a control group.
Results: Children with epilepsy who were treated with AEDs showed higher behavioral problems scales, lower mean IQ and lower executive functions as compared to controls. LEV and VPA had a more negative effect on behavior than CBZ and OXC while VPA and CBZ had a more negative effect on mean IQ and executive functions than LEV and OXC.
Conclusion: Antiepileptic drugs (AEDs) may be one of the causes of epilepsy-related cognitive and behavioral issues in children.
Keywords:
- Cognitive and behavioral impacts
- idiopathic epilepsy
- antiepileptic drugs
- children and adolescents
How to Cite
References
Neligan A, Adan G, Nevitt SJ, Pullen A, Sander JW, Marson AG. Prognosis of adults and children following a first unprovoked seizure. Cochrane Database of Systematic Reviews; 2021.
Shorvon S. The concept of symptomatic epilepsy and the complexities of assigning cause in epilepsy. Epilepsy & Behavior. 2014;32:1-8.
Inder TE, Matthews LG. Neonatal Brain Disorders. Klaus and Fanaroff's Care of the High-Risk Neonate E-Book. 2019;386.
Yang W, Zhang X, Long J, Wu Q, Han Y. Prediction of the recurrence risk in patients with epilepsy after the withdrawal of antiepileptic drugs. Epilepsy & behavior. 2020;110:107156.
Fatima N, Chinnakali P, Rajaa S, Menon V, Mondal N, Chandrasekaran V. Prevalence of depression and anxiety among mothers of children with neuro-developmental disorders at a tertiary care centre, Puducherry. Clinical Epidemiology and Global Health. 2021;11:100792.
Vorderwülbecke BJ, Wandschneider B, Weber Y, Holtkamp M. Genetic generalized epilepsies in adults—challenging assumptions and dogmas. Nature Reviews Neurology. 2021;1-13.
Ahmed NSE-d, Nada MA, Amin RM, Ali OSK, Ibrahim MH. Comorbidity of Attention-Deficit / Hyperactivity Disorder (ADHD) in Children with Epilepsy, Egyptian Study. Neuroscience and Medicine. 2020; 11:119.
Ring A, Jacoby A, Baker G, Holmes E, Hughes D, Kierans C, et al. What really matters? A mixed methods study of treatment preferences and priorities among people with epilepsy in the UK. Epilepsy & Behavior. 2019;95:181-91.
Halder T, Michl P, Flanagin V, Schenk T. Impaired emotion processing and panic disorder after left anterior temporal lobectomy: A case report of successful psychotherapeutic intervention. Cognitive Therapy and Research. 2022;1-14.
Pototskiy E, Dellinger JR, Bumgarner S, Patel J, Sherrerd-Smith W, Musto AE. Brain injuries can set up an epileptogenic neuronal network. Neuroscience & Biobehavioral Reviews. 2021;129:351-66.
El Tantawi NT, Hamdey I. Behavioral problems in children with epilepsy: a case–control study. Alexandria Journal of Pediatrics. 2019;32:41.
Mishra OP, Upadhyay A, Prasad R, Upadhyay SK, Piplani SK. Behavioral problems in Indian children with epilepsy. Indian Pediatrics. 2017;54:116-20.
Sarhan AA, Ayouty MM, Elsharkawy AA, Abd Elmagid DS. Neurodevelopmental and neurobehavioral aspects of childhood epilepsy. Benha Medical Journal. 2015; 32:13.
Loutfi KS, Carvalho AM, Lamounier JA, de Almeida Nascimento J. ADHD and epilepsy: contributions from the use of behavioral rating scales to investigate psychiatric comorbidities. Epilepsy & Behavior. 2011;20:484-9.
Ahmed EE, Mohamed IN. Spectrum of attention deficit hyperactivity disorders (ADHD) among Sudanese children with epilepsy. Sudanese Journal of Paediatrics. 2015;15:42.
Piccinelli P, Beghi E, Borgatti R, Ferri M, Giordano L, Romeo A, et al. Neuropsychological and behavioral aspects in children and adolescents with idiopathic epilepsy at diagnosis and after 12 months of treatment. Seizure. 2010; 19:540-6.
Lagae L, Buyse G, Ceulemans B. Clinical experience with levetiracetam in childhood epilepsy: an add-on and mono-therapy trial. Seizure. 2005;14:66-71.
Thelengana A, Shukla G, Srivastava A, Singh MB, Gupta A, Rajan R, et al. Cognitive, behavioral and sleep-related adverse effects on introduction of levetiracetam versus oxcarbazepine for epilepsy. Epilepsy research. 2019;150: 58-65.
Tekgül H, Gencpinar P, Çavuşoğlu D, Dündar NO. The efficacy, tolerability and safety of levetiracetam therapy in a pediatric population. Seizure. 2016;36: 16-21.
El-Sayed Ismail A, Kawashti Gad H, Hamed Rashad M. Cognitive assessment in a sample of Egyptian patients with generalized onset epilepsy. Al-Azhar Medical Journal. 2020;49:125-36.
Schiemann-Delgado J, Yang H, Loge Cdl, Stalvey TJ, Jones J, LeGoff D, et al. A long-term open-label extension study assessing cognition and behavior, tolerability, safety, and efficacy of adjunctive levetiracetam in children aged 4 to 16 years with partial-onset seizures. Journal of Child Neurology. 2012;27:80-9.
Donati F, Gobbi G, Campistol J, Rapatz G, Daehler M, Sturm Y, et al. The cognitive effects of oxcarbazepine versus carbamazepine or valproate in newly diagnosed children with partial seizures. Seizure. 2007;16:670-9.
Hanci F, Canpolat M, Per H, Gumus H, Kumandas S. The relation between antiepileptic drug type and cognitive functions in childhood epilepsy: a prospective observational study. Experimental Biomedical Research. 2019; 2:62-8.
-
Abstract View: 45 times
PDF Download: 15 times
